HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

forbesione

structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- forbesione: 3

Experts

1.	Anantachoke, Natthinee: 3 articles (12/2017 - 01/2014)
2.	Hahnvajanawong, Chariya: 3 articles (12/2017 - 01/2014)
3.	Reutrakul, Vichai: 3 articles (12/2017 - 01/2014)
4.	Boonmars, Thidarut: 2 articles (12/2017 - 12/2016)
5.	Boueroy, Parichart: 2 articles (12/2017 - 12/2016)
6.	Wattanawongdon, Wareeporn: 2 articles (12/2017 - 01/2014)
7.	Kongsanthia, Charuphan: 1 article (12/2017)
8.	Saensa-ard, Sunitta: 1 article (12/2017)
9.	Salao, Kanin: 1 article (12/2017)
10.	Wongwajana, Suwin: 1 article (12/2017)

Related Diseases

1.	Cholangiocarcinoma 12/01/2016 - "Antitumor effect of forbesione isolated from Garcinia hanburyi on cholangiocarcinoma in vitro and in vivo." 12/29/2017 - "This study aimed to investigate the synergistic effects of forbesione combined with 5-fluorouracil (5-FU) in hamster cholangiocarcinoma (Ham-1) cells both in vitro and in vivo. " 12/29/2017 - "Synergistic Effect of Forbesione From Garcinia hanburyi in Combination with 5-Fluorouracil on Cholangiocarcinoma" 01/01/2014 - "Synergistic effects of isomorellin and forbesione with doxorubicin on apoptosis induction in human cholangiocarcinoma cell lines."
2.	Neoplasms (Cancer) 12/01/2016 - "Thus, forbesione is a potential drug candidate for cancer therapy that deserves further investigation." 12/29/2017 - "In vivo studies, forbesione in combination with 5-FU exhibited greater inhibition of the tumor in the hamster model compared with treatment using either drug alone. " 12/29/2017 - "The anti-tumor effects of 5-FU combined with forbesione in vitro were determined using the Sulforhodamine B (SRB) assay and the effects in vivo were assessed in transplanted Ham-1 allograph models. " 12/01/2016 - "This was mediated by decreasing the protein expression of cyclin E, cyclin A and cyclin-dependent kinase 2. In addition, increased expression of p21 and p27 was detected, which could possibly explain the reduced expression of proliferating cell nuclear antigen and of the bile duct cell marker cytokeratin 19 observed in forbesione-treated Ham-1 cells in vitro and in tumor tissues of forbesione-treated hamsters. "

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	Keratin-19 (Keratin 19)
3.	Cyclin-Dependent Kinase 2
4.	Cyclin E
5.	Cyclin A
6.	Proliferating Cell Nuclear Antigen (PCNA)
7.	Proteins (Proteins, Gene)
8.	Doxorubicin (Adriamycin)
9.	isomorellin
10.	lissamine rhodamine B (sulforhodamine B)

Related Therapies and Procedures

1.	Therapeutics